In addition to REGENCY, Gazyva is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and ...

In addition to REGENCY, Gazyva/Gazyvaro is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and ...

Gazyva is also being studied in children and adolescents with lupus nephritis and patients with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and SLE. The SLE market is ...

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN ... Gazyva is being studied in children and adolescents with ...

WA cases of a kidney disease which most commonly affects children following a skin or throat infection has doubled in the ...

A bereaved mother has told an inquiry that her toddler could have been saved from a fatal infection if doctors had caught it ...

Miles Casas, a 30-year-old man from New Canaan, has been battling kidney failure for the past five years. Diagnosed with ...

Obinutuzumab is also currently being studied in children and adolescents with lupus nephritis, patients with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and systemic lupus ...

In addition to REGENCY, Gazyva is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and systemic ...

The tubulointerstitial compartment comprises most of the kidney parenchyma. Inflammation in this compartment (tubulointerstitial nephritis-TIN) can be acute and resolves if the offending factor is ...

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...